scholarly journals Astrocytic Process Plasticity and IKKβ/NF-κB in Central Control of Blood Glucose, Blood Pressure, and Body Weight

2017 ◽  
Vol 25 (5) ◽  
pp. 1091-1102.e4 ◽  
Author(s):  
Yalin Zhang ◽  
Judith M. Reichel ◽  
Cheng Han ◽  
Juan Pablo Zuniga-Hertz ◽  
Dongsheng Cai
Keyword(s):  
Blood Pressure ◽  
Body Weight ◽  
Blood Glucose ◽  
Central Control ◽  
Astrocytic Process

scholarly journals Glycaemic Control, Lipid Profile, Blood Pressure and Body Weight Status Among Diabetics in Rural Malaysia

2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Hazizi AS ◽  
Zaitun Y ◽  
Kandiah M ◽  
Chan SP
Keyword(s):  
Blood Pressure ◽  
Body Weight ◽  
Blood Glucose ◽  
Glycaemic Control ◽  
Lipid Profile ◽  
Weight Status ◽  
Density Lipoprotein ◽  
Lipoprotein Cholesterol ◽  
Body Weight Status

Introduction: Diabetes is associated with a high risk of cardiovascular disease. The management of blood glucose, dyslipidaemia and other modifiable risk factor, is a key element in the multifactorial approach to prevent complications of type 2 diabetes. Materials and Methods: A cross sectional study was conducted to determine the level of glycaemic control, lipid profile, blood pressure and body weight status among type 2 diabetics in rural Malaysia. A total of 237 diabetic subjects participated in this study. Physical examination was carried out, including measurements of height, weight, waist and hip circumferences, and systolic and diastolic blood pressure. Fasting venous blood samples were collected to determine the glucose level and lipid profile. Results: About 70% of the subjects had a high body mass index (BMI), equal to or above 25 kg/ m2. More than 60% of the subjects had systolic blood pressure ≥ 140 mmHg and/or diastolic ≥ 90 mmHg. Mean fasting blood glucose was 9.84±4.54 mmol/L. Mean total cholesterol was 5.18±1.35 mmol/L. High density lipoprotein cholesterol (HDLC) and triglyceride (TG) and glucose levels were higher in male than in female, but not statistically significant (p>0.05). However, low density lipoprotein cholesterol (LDLC) was higher in females than males (p<0.05). Mean HDLC was below 1.0 mmol/L in all subjects. Conclusion: Glycaemic control, lipid profile, blood pressure and body weight status were not satisfactory and may increase the risk of microvascular and macrovascular complications among these subjects. Appropriate intervention programs should be implemented for better diabetes control among rural subjects.

Diet enriched with fresh coconut decreases blood glucose levels and body weight in normal adults

2018 ◽  
Vol 15 (3) ◽  
Author(s):  
Venugopal Vijayakumar ◽  
Nagashree R. Shankar ◽  
Ramesh Mavathur ◽  
A. Mooventhan ◽  
Sood Anju ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Body Weight ◽  
Fatty Acid ◽  
Blood Glucose ◽  
Blood Sugar ◽  
Fiber Intake ◽  
Groundnut Oil ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Fresh Coconut

Abstract Background There exist controversies about the health effects of coconut. Fresh coconut consumption on human health has not been studied substantially. Fresh coconut consumption is a regular part of the diet for many people in tropical countries like India, and thus there is an increasing need to understand the effects of fresh coconut on various aspects of health. Aim To compare the effects of increased saturated fatty acid (SFA) and fiber intake, provided by fresh coconut, versus monounsaturated fatty acid (MUFA) and fiber intake, provided by a combination of groundnut oil and groundnuts, on anthropometry, serum insulin, glucose levels and blood pressure in healthy adults. Materials Eighty healthy volunteers, randomized into two groups, were provided with a standardized diet along with either 100 g fresh coconut or an equivalent amount of groundnuts and groundnut oil for a period of 90 days. Assessments such as anthropometric measurements, blood pressure, blood sugar and insulin levels were performed before and after the supplementation period. Results Results of this study showed a significant reduction in fasting blood sugar (FBS) in both the groups. However, a significant reduction in body weight was observed in the coconut group, while a significant increase in diastolic pressure was observed in the groundnut group. Conclusions Results of this study suggest that fresh coconut-added diet helps reduce blood glucose levels and body weight in normal healthy individuals.

scholarly journals LIGHT-ROASTED GREEN COFFEE EXTRACT IMPROVED ADIPONECTIN, INSULIN RESISTANCE, AND METABOLIC PROFILE OF METABOLIC SYNDROME RAT MODEL

2017 ◽  
Vol 10 (9) ◽  
pp. 279 ◽  
Author(s):  
Mifetika Lukitasari ◽  
Dwi Adi Nugroho ◽  
Mohammad Saifur Rohman ◽  
Nur Ida Panca Nugrahini ◽  
Teguh Wahyu Sardjono
Keyword(s):  
Insulin Resistance ◽  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Body Weight ◽  
Blood Glucose ◽  
Metabolic Profile ◽  
Adiponectin Level ◽  
Fasting Blood Glucose ◽  
Enzyme Linked Immunosorbent Assay ◽  
Green Coffee

  Objective: The objective of this study is to investigate the effect of light-roasted green coffee bean extract (GCE) administration for 7 weeks on the improvement of metabolic profile, adiponectin level, homeostatic model assessment insulin resistance (HOMA-IR) index in metabolic syndrome (MS) rat model.Methods: Adult male Sprague-Dawley rats were induced by a combination of high sucrose and high-fat diet for 8 weeks and streptozotocin injection in the 2nd week. The MS was confirmed by NCEP-ATP III criteria. They were divided into six weight-matched groups (n=5), normal control, MS, metformin and simvastatin-treated group (DMS), 100 and 200/body weight (bw) GCE (GCE 100 and GCE 200, respectively). The extracts were given through oral gavage daily for 7 weeks. The effect of GCE on body weight, serum glucose, triglyceride, (TG) and high-density lipoprotein (HDL) level was analyzed by colorimetric method. HOMA-IR index and adiponectin were analyzed by enzyme-linked immunosorbent assay methods.Result: Fasting blood glucose, TG, and systolic blood pressure decreased significantly (p<0.05) in both GCE groups. Moreover, after 7 weeks, those parameters were significantly lower (p<0.05) compared to that of MS group. Only GCE 100 group that showed a significant decrease in HDL level. GCE 100 mg/bw and 200 mg/bw group showed significantly higher adiponectin level compared to that of MS and DMS group. Furthermore, GCE 100, GCE 200, and DMS group showed a significant lower HOMA-IR index compared to that of MS group.Conclusion: 7 weeks GCE administration could decrease fasting blood glucose, profile lipid, blood pressure, and improved adiponectin level and HOMA-IR index.

Acupuncture and related techniques for obesity and cardiovascular risk factors: a systematic review and meta-regression analysis

2020 ◽  
Vol 38 (4) ◽  
pp. 227-234
Author(s):  
Jianrong Chen ◽  
Dongping Chen ◽  
Qing Ren ◽  
Weifeng Zhu ◽  
Sheng Xu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Body Weight ◽  
Cardiovascular Risk ◽  
Blood Glucose ◽  
Cardiovascular Risk Factors ◽  
Density Lipoprotein ◽  
Moderate Quality ◽  
Meta Regression ◽  
Quality Evidence

Objective: To assess how acupuncture and related techniques affect weight-related indicators and cardiovascular risk factors compared with non-acupuncture interventions in overweight and obese patients. Methods: We searched PubMed, Embase and CENTRAL up to 19 April 2018 and included relevant randomised controlled trials (RCTs). Weighted mean differences (WMDs) and 95% confidence intervals (CI) were pooled using the inverse variance method with random-effects model. Prespecified hypotheses were tested in meta-regression to investigate the source of heterogeneity. Statistical software packages used were RevMan 5.3.5 and Stata 14.0. Results: Thirty-three RCTs were included (n=2503 patients). Compared with non-acupuncture interventions, acupuncture produced a greater reduction in body weight (WMD −1.76 kg, 95% CI −2.22 to −1.30, I2=77%; moderate quality), body mass index (WMD −1.13 kg/m2, 95% CI −1.38 to −0.88, I2=85%; low quality) and waist circumference (WMD −2.42 cm, 95% CI −3.22 to −1.62, I2=75%; moderate quality). Acupuncture plus lifestyle intervention resulted in a greater reduction in body weight than acupuncture alone (MD −1.94 kg, 95% CI −3.17 to −0.70). Acupuncture also led to a greater reduction in total cholesterol (WMD −12.87 mg/dL, 95% CI −22.17 to −3.57, I2=87%; very low quality) and low-density lipoprotein cholesterol (WMD −13.52 mg/dL, 95% CI −21.47 to −5.58, I2=74%; low quality). The differences were not statistically significant for blood glucose or blood pressure. Conclusion: In the short term, acupuncture and related techniques may produce a small but statistically significant degree of weight loss based on moderate- to low-quality evidence, and improve serum lipid parameters based on low- to very-low-quality evidence. Their effects on blood glucose and blood pressure remain uncertain.

Chia seed (Salvia hispanica L.) supplementation to the diet of adults with type 2 diabetes improved systolic blood pressure: A randomized controlled trial

2021 ◽  
pp. 026010602098181
Author(s):  
Eman Zaid Marzouq Alwosais ◽  
Ebaa Al-Ozairi ◽  
Tasleem A Zafar ◽  
Sharifa Alkandari
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Body Weight ◽  
Blood Glucose ◽  
Lipid Profile ◽  
Inflammatory Marker ◽  
Control Group ◽  
Food Ingredients ◽  
Chia Seed

Background: Functional food ingredients, such as dietary fiber, long-chain polyunsaturated fatty acids, and high-quality protein, have been shown to help control blood glucose concentration and lower high blood pressure (BP), as well as improving other cardiovascular disease risk factors. However, little research has assessed the impacts of consuming chia seeds, which are rich in these nutrients, on metabolic and physiological outcomes, and results are conflicting. Aim: The study aimed to investigate the possible effects of chia seeds on fasting blood glucose, insulin, glycated hemoglobin, BP, lipid profile, body weight, and the inflammatory marker – high-sensitivity C-reactive protein – in people with type 2 diabetes (T2DM). Methods: Adults with T2DM ( n = 42) were randomly assigned equally to the chia seed group, which consumed 40 g/day chia seeds for 12 weeks, or a control group, which did not consume any supplement. Blood samples were collected at baseline and after a 12-week intervention period to assess the study outcomes, such as glycemic control, BP, cardiovascular risk parameters including lipid profile, inflammatory marker, and body weight. Results: Adjusted for gender and baseline values, the chia seed group had systolic BP (SBP) significantly reduced compared to control [ t (1) = 2.867, p = 0.007, η 2 p = 0.174]. No differences were observed in any other parameter tested in the chia seed or control group. Conclusions: People with T2DM and hypertension, maintaining usual dietary consumption, physical activity pattern, and medications, had significantly reduced SBP compared to the control group when having consumed 40 g/d of chia seeds for 12 weeks.

scholarly journals Association between Serum Prolactin and Metabolic Disorders: a Systematic Review

2020 ◽  
Author(s):  
Zaibo Yang ◽  
Junsen She ◽  
Congcong Zhou ◽  
Liangshan Mu
Keyword(s):  
Systematic Review ◽  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Body Weight ◽  
Blood Glucose ◽  
Lower Risk ◽  
Metabolic Disorders ◽  
Blood Lipids ◽  
Serum Prolactin

Background: Serum prolactin levels are associated with metabolic disorders. However, the conclusions were inconsistent among published studies. Methods: PubMed, EMBASE, and the Cochrane Library were used to search for studies investigating the association between serum prolactin levels and metabolic disorders. Studies were included and reviewed if they reported the association between serum prolactin and metabolic components (including waist circumference, body weight indexes, blood pressure, blood glucose, blood lipids, insulin resistance, and type 2 diabetes). Results: A total of 14 studies were included in this systematic review. Evidence for certain associations between serum prolactin levels and body weight, blood lipids, blood glucose was insufficient, while some evidence showed a positive association between serum prolactin and blood pressure. High serum prolactin levels were found to be associated with lower risk of type 2 diabetes in women but not in men, but evidence for an exact correlation between serum prolactin and type 2 diabetes was insufficient. Conclusion: Evidence for associations between serum prolactin and metabolic profiles were insufficient. Higher serum prolactin levels might be associated with lower risk of type 2 diabetes in women. Further high-quality prospective studies are required.

scholarly journals Short Term Effects of Fresh Garlic (Allium Sativum) on Blood Lipids, Blood Pressure, Blood Glucose, Haemoglobin Concentration and Body Weight of Overweight Young Adults

2011 ◽  
Vol 16 (Number 1) ◽  
pp. 13-17
Author(s):  
AFM M Rahman ◽  
Md. M Huq ◽  
R Ahmed ◽  
F Hamid
Keyword(s):  
Blood Pressure ◽  
Body Weight ◽  
Blood Glucose ◽  
Allium Sativum ◽  
Blood Lipids ◽  
Low Density Lipoprotein ◽  
Haemoglobin Concentration ◽  
Density Lipoprotein ◽  
Average Weight ◽  
Short Term

This study was done to observe the short tens effect of fresh garlic on different lipid profiles, blood glucose, blood pressure (BP), body weight and haemoglobin (11b) concentration in healthy but overweight (average weight 88.89 kg) adult ( both male and female). Fresh garlic, one clove (average wt. 4 to 6 gm), was taken everyday with night meal by the volunteers for six weeks. The volunteers were mostly students and a few of them were office staff Total number of volunteers were 25. Administration of garlic significantly lowered cholesterol (p<61.001) and low density lipoprotein (p<0.05), but there was no effect on BP, body weight and IIb concentration. Garlic administration reduced the level of blood glucose and triglyceride (TG) to some extent but they were not statistically significant.

scholarly journals Effectiveness of Ascophyllum nodosum and Fucus vesiculosus on Metabolic Syndrome Components: A Real-World, Observational Study

2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Antonio Nicolucci ◽  
Maria Chiara Rossi ◽  
Massimiliano Petrelli
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Body Weight ◽  
Blood Glucose ◽  
Waist Circumference ◽  
Real World ◽  
Fasting Blood Glucose ◽  
Ascophyllum Nodosum ◽  
Fucus Vesiculosus ◽  
The Metabolic Syndrome

Introduction. Gdue is a nutraceutical obtained from the association of two marine algae, Ascophyllum nodosum and Fucus vesiculosus, in addition to chromium picolinate, which could be useful for the treatment of dysglycemia, overweight, and the other components of the metabolic syndrome. The aim of the study was to assess the real-world effectiveness and safety of Gdue when administered to subjects with one or more components of the metabolic syndrome. Methods. A longitudinal, retrospective, observational study, conducted among primary care physicians, nutritionists, and specialists from various disciplines. The impact of 180 days of administration of Gdue was assessed on body weight, waist circumference, fasting blood glucose, HbA1c, lipid profile, and blood pressure levels. The likelihood of experiencing a first major cardiovascular event over ten years was estimated using Italian risk charts. General linear models for repeated measures were applied to assess changes in the parameters of interest during the follow-up. Results are expressed as estimated marginal means with their 95% confidence interval. Results. Overall, 505 patients were enrolled by 282 physicians. After 6 months of treatment with Gdue, body weight was reduced on average by 7.3 kg (-8.0; -6.6), waist circumference by 7.5 cm (-8.2; -6.8), fasting blood glucose by 16.3 mg/dL (-17.8; -14.7), HbA1c by 0.55% (-0.62; -0.49), systolic and diastolic blood pressure by 7.1 mmHg (-8.3; -6.0) and 4.2 mmHg (-5.0; -3.5), respectively, LDL cholesterol by 18.2 mg/dL (-21.2; -15.3), and triglycerides by 39 mg/dL (-45; -32). HDL cholesterol was significantly increased by 2.9 mg/dL (0.7; 5.0). The 10-year risk of cardiovascular events significantly decreased by 1.8%, corresponding to a relative risk reduction of 27.7%. Conclusion. Our real-world study shows that 6 months of treatment with Gdue have an impact on all the components of the metabolic syndrome, thus offering the potential for decreasing the cardiovascular risk associated with metabolic syndrome.

Sign in / Sign up

Export Citation Format

Share Document